Weiss Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,638
Closed -$5.08M 810
2026
Q1
$5.08M Buy
22,638
+16,869
+292% +$4.2M 0.09% 172
2025
Q4
$1.39M Buy
5,769
+2,565
+80% +$656K 0.02% 361
2025
Q3
$877K Buy
+3,204
New +$875K 0.01% 371
2024
Q4
Sell
-1,944
Closed -$475K 837
2024
Q3
$475K Buy
+1,944
New +$434K 0.01% 514
2022
Q4
Sell
-12,950
Closed -$2.83M 640
2022
Q3
$2.83M Buy
+12,950
New +$2.95M 0.07% 341
2021
Q3
Sell
-5,379
Closed -$1.33M 599
2021
Q2
$1.33M Buy
+5,379
New +$1.13M 0.03% 342

Other funds holding RMD

Weiss Asset Management's RMD Position: Q2 2026 in Review

Weiss Asset Management sold out of ResMed (RMD) in Q2 2026, closing a stake of 22,638 shares — an estimated $5.08M sold.

Weiss Asset Management first reported a position in RMD in Q2 2021 and held it in 6 quarters. The position peaked at $5.08M in Q1 2026. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Weiss Asset Management reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 22,638 ResMed shares in Q2 2026, an estimated $5.08M.
  • Weiss Asset Management first reported a position in ResMed in Q2 2021 and held it in 6 quarters.
  • Weiss Asset Management's ResMed position peaked at $5.08M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.